{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T02:19:48Z","timestamp":1720145988776},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.lfs.2018.12.062","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T02:22:05Z","timestamp":1546482125000},"page":"74-81","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preprodynorphin gene mutation causes progressive cardiac conduction disease: A whole-exome analysis of a pedigree"],"prefix":"10.1016","volume":"219","author":[{"given":"Jian-Yao","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Xue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Meng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Long","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Zong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/HCO.0000000000000134","article-title":"Inherited progressive cardiac conduction disorders","volume":"30","author":"Baruteau","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0010","first-page":"127","article-title":"Conduction defects\/cardiomyopathies","volume":"61","author":"Gilbert-Barness","year":"2014","journal-title":"Adv. Pediatr. Infect. Dis."},{"issue":"7261","key":"10.1016\/j.lfs.2018.12.062_bb0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted capture and massively parallel sequencing of 12 human exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"issue":"45","key":"10.1016\/j.lfs.2018.12.062_bb0020","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.lfs.2018.12.062_bb0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.1975","article-title":"Performance comparison of exome DNA sequencing technologies","volume":"29","author":"Clark","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2018.12.062_bb0030","first-page":"1099","article-title":"Studies on the site of analgesic action of morphine by intracerebral microinjection","author":"Tsou","year":"1964","journal-title":"Sci. Sinica"},{"issue":"6","key":"10.1016\/j.lfs.2018.12.062_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/jmcc.1994.1085","article-title":"Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat","volume":"26","author":"Caffrey","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2018.12.062_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1113\/expphysiol.2014.083436","article-title":"Involvement of the \u03b4-opioid receptor in exercise-induced cardioprotection","volume":"1;100","author":"Miller","year":"2015","journal-title":"Exp. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2018.12.062_bb0045","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1073\/pnas.83.6.1960","article-title":"Proenkephalin mRNA in rat heart","volume":"83","author":"Howells","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2018.12.062_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00380-014-0620-6","article-title":"Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats","volume":"31","author":"Treskatsch","year":"2016","journal-title":"Heart Vessel."},{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hfc.2017.08.001","article-title":"Proenkephalin in heart failure","volume":"14","author":"Siong Chan","year":"2018","journal-title":"Heart Fail. Clin."},{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jss.2003.12.006","article-title":"Relative contribution of endogenous opioids to myocardial ischemic tolerance","volume":"118","author":"Romano","year":"2004","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.lfs.2018.12.062_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0008-6363(02)00439-X","article-title":"Mitochondrial K(ATP) channels: role in cardioprotection","volume":"55","author":"Oldenburg","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1152\/physrev.00003.2015","article-title":"KATP channels in the cardiovascular system","volume":"96","author":"Foster","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2018.12.062_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0022-2828(90)90080-L","article-title":"Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart\u2013an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis","volume":"22","author":"Wong","year":"1990","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2018.12.062_bb0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"issue":"41","key":"10.1016\/j.lfs.2018.12.062_bb0085","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.lfs.2018.12.062_bb0090","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm."},{"issue":"5","key":"10.1016\/j.lfs.2018.12.062_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ajhg.2010.10.001","article-title":"Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23","volume":"87","author":"Bakalkin","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2018.12.062_bb0100","first-page":"329","article-title":"Heart rate variability in type 2 spinocerebellar ataxia","volume":"122","author":"Montes-Brown","year":"2010","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.lfs.2018.12.062_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.2007.00945.x","article-title":"Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability","volume":"117","author":"Pradhan","year":"2008","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.lfs.2018.12.062_bb0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0735-1097(02)02864-4","article-title":"Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease","volume":"41","author":"Probst","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2018.12.062_bb0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccep.2010.09.007","article-title":"Progressive conduction diseases","volume":"2","author":"Martin","year":"2010","journal-title":"Card. Electrophysiol. Clin."},{"issue":"11","key":"10.1016\/j.lfs.2018.12.062_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF03086296","article-title":"Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide","volume":"17","author":"Postema","year":"2009","journal-title":"Neth. Hear. J."},{"issue":"7","key":"10.1016\/j.lfs.2018.12.062_bb0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI200318062","article-title":"Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)","volume":"112","author":"Benson","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5373","key":"10.1016\/j.lfs.2018.12.062_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1126\/science.281.5373.108","article-title":"Congenital heart disease caused by mutations in the transcription factor NKX2-5","volume":"281","author":"Schott","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2018.12.062_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00059-009-3215-8","article-title":"Genes causing inherited forms of cardiomyopathies. A current compendium","volume":"34","author":"Paul","year":"2009","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.lfs.2018.12.062_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(95)01434-9","article-title":"Cardiovascular effects of Leu-enkephalin in the nucleus tractus solitarius of the rat","volume":"709","author":"Feldman","year":"1996","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2018.12.062_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0163-7258(00)00106-6","article-title":"Opioids and cardioprotection","volume":"89","author":"Schultz","year":"2001","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2018.12.062_bb0150","doi-asserted-by":"crossref","first-page":"H1032","DOI":"10.1152\/ajpheart.01004.2002","article-title":"Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels","volume":"285","author":"Cao","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2018.12.062_bb0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.bjp.0705475","article-title":"Roles of KATP channels in delayed cardioprotection and intracellular Ca(2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H","volume":"140","author":"Chen","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2018.12.062_bb0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2009.01.050","article-title":"Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis","volume":"607","author":"Yin","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.12.062_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11010-010-0577-4","article-title":"Effect of U50,488H, a kappa-opioid receptor agonist on myocardial alpha-and beta-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat","volume":"345","author":"Jaiswal","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2018.12.062_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2015.09.005","article-title":"Upregulation of the kappa opioidergic system in left ventricular rat myocardium in response to volume overload: adaptive changes of the cardiac kappa opioid system in heart failure","volume":"102","author":"Treskatsch","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2018.12.062_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0163-7258(02)00165-1","article-title":"The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system","volume":"93","author":"Pugsley","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"37","key":"10.1016\/j.lfs.2018.12.062_bb0180","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.2174\/138161212803582360","article-title":"Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems","volume":"18","author":"Headrick","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2018.12.062_bb0185","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1111\/j.1540-8159.2005.00073.x","article-title":"Expression of opioid receptor subtypes and their ligands in fibrillating human atria","volume":"28","author":"Lendeckel","year":"2005","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"6","key":"10.1016\/j.lfs.2018.12.062_bb0190","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2015.1045","article-title":"Association between opioid use and atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study","volume":"175","author":"Qureshi","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"Pt 2","key":"10.1016\/j.lfs.2018.12.062_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-7793.1999.0347m.x","article-title":"ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria","volume":"519","author":"Holmuhamedov","year":"1999","journal-title":"J. Physiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T19:31:33Z","timestamp":1549740693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518308646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":39,"alternative-id":["S0024320518308646"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.062","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preprodynorphin gene mutation causes progressive cardiac conduction disease: A whole-exome analysis of a pedigree","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}